Overview

Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

Status:
Completed
Trial end date:
2017-10-15
Target enrollment:
Participant gender:
Summary
This study compared two main different induction protocols used to treat myeloma eligible patients in Brazil. VCD against CTD.
Phase:
Phase 3
Details
Lead Sponsor:
Grupo de Estudos Multicentricos em Onco-Hematologia
Treatments:
BB 1101
Bortezomib
Cyclophosphamide
Dexamethasone
Dexamethasone acetate
Thalidomide